Location History:
- Tuebingen, DE (2007)
- Herrenberg, DE (2008)
Company Filing History:
Years Active: 2007-2008
Title: Wichard Vogel: Innovator in Monoclonal Antibody Research
Introduction
Wichard Vogel is a notable inventor based in Herrenberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, his work focuses on isolating and identifying stem cells, which has important implications for medical research and therapies.
Latest Patents
Vogel's latest patents include a monoclonal antibody known as W8B2, which is designed for isolating and identifying mesenchymal stem cells. This invention involves an antibody that binds to a specific antigen, similar to that of the antibody produced by the hybridoma cell line W8B2, which was deposited in the DSMZ under the number DSM ACC2567 on August 14, 2002. Additionally, he has developed antibodies for isolating and identifying neuronal stem cells. This invention also relates to monoclonal antibodies that bind to an identical antigen as those produced by hybridoma cell lines W4A5, W8C3, and 57D2, which were deposited at the DSMZ under the numbers DSM ACC2571, DSM ACC2570, and DSM ACC2568.
Career Highlights
Wichard Vogel is affiliated with the Eberhard Karls University Tuebingen Universitätsklinikum, where he conducts his research. His work has been instrumental in advancing the understanding of stem cell biology and its applications in regenerative medicine.
Collaborations
Vogel has collaborated with notable colleagues such as Hans-Jorg Buhring and Reiner Lammers, contributing to the collective knowledge and advancements in the field of monoclonal antibodies.
Conclusion
Wichard Vogel's innovative work in monoclonal antibody research has paved the way for significant advancements in stem cell identification and isolation. His contributions continue to impact the field of biotechnology and medical research.